{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:29:46Z","timestamp":1792016986028,"version":"4.4.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.phrs.2016.01.033","type":"journal-article","created":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T13:06:18Z","timestamp":1454331978000},"page":"119-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":368,"special_numbering":"C","title":["Cannabidiol, neuroprotection and neuropsychiatric disorders"],"prefix":"10.1016","volume":"112","author":[{"given":"Alline C.","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoela V.","family":"Foga\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreza B.","family":"Sonego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco S.","family":"Guimar\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2016.01.033_bib0005","unstructured":"World Health Organization. WHO methods and data sources for global burden of disease estimates 2000\u20132011. Department of Health Statistics and Information Systems WHO, Geneva (2013)."},{"key":"10.1016\/j.phrs.2016.01.033_bib0010","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s12041-014-0449-x","article-title":"Molecular and genetic basis of depression","volume":"93","author":"Roy","year":"2014","journal-title":"J. Genet."},{"key":"10.1016\/j.phrs.2016.01.033_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fpsyt.2015.00068","article-title":"Gene-environment interaction in major depression: focus on experience-dependent biological systems","volume":"6","author":"Lopizzo","year":"2015","journal-title":"Front. Psychiatry"},{"issue":"208","key":"10.1016\/j.phrs.2016.01.033_bib0020","article-title":"Mechanisms underlying the antidepressant response and treatment resistance","volume":"8","author":"Levinstein","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.npp.1301564","article-title":"Drug addiction as a pathology of staged neuroplasticity","volume":"33","author":"Kalivasand O\u2019Brien","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0030","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamapsychiatry.2013.1","article-title":"Neuronal network plasticity and recovery from depression","volume":"70","author":"Castren","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.phrs.2016.01.033_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2015.09.013","article-title":"Translating depression biomarkers for improved targeted therapies","volume":"59","author":"Bredt","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.phrs.2016.01.033_bib0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.9758\/cpn.2014.12.2.83","article-title":"Therapeutic modalities for treatment resistant depression: focus on vagal nerve stimulation and ketamine","volume":"12","author":"Shah","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.comppsych.2015.11.010","article-title":"Brain-derived neurotrophic factor serum levels in heroin-dependent patients after 26weeks of withdrawal","volume":"65","author":"Zhang","year":"2016","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.phrs.2016.01.033_bib0050","article-title":"Depression and anxiety are co-morbid but dissociable in mild Parkinson's disease: A prospective longitudinal study of patterns and predictors","author":"Wee","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.phrs.2016.01.033_bib0055","article-title":"An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice","volume":"6","author":"Sheline","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2016.01.033_bib0060","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1161\/STROKEAHA.115.010471","article-title":"Fluoxetine maintains a state of heightened responsiveness to motor training early after stroke in a mouse model","volume":"46","author":"Ng","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2016.01.033_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0896-6273(02)00653-0","article-title":"Neurobiology of depression","volume":"34","author":"Nestler","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2016.01.033_bib0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000356188","article-title":"Maternal separation induces alterations in reversal learning and brain-derived neurotrophic factor expression in adult rats","volume":"68","author":"Xue","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.neuropharm.2011.04.033","article-title":"Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells","volume":"61","author":"Liu","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbi.2015.01.016","article-title":"Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance","volume":"46","author":"Ramirez","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.phrs.2016.01.033_bib0085","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2012.04341.x","article-title":"Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?","volume":"75","author":"Fernandez-Ruiz","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol","volume":"66","author":"Russo","year":"2006","journal-title":"Med. Hypotheses."},{"key":"10.1016\/j.phrs.2016.01.033_bib0100","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0040-4020(65)80064-3","article-title":"The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids","volume":"21","author":"Mechoulam","year":"1965","journal-title":"Tetrahedron"},{"key":"10.1016\/j.phrs.2016.01.033_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/3-540-26573-2_1","article-title":"Pharmacological actions of cannabinoids","author":"Pertwee","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0110","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2015.12.017","article-title":"Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT\/glutamate neurotransmission: role of 5-HT receptors","volume":"103","author":"Linge","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0120","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuroscience.2014.12.051","article-title":"Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of cerebral malaria","volume":"289","author":"Campos","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2016.01.033_bib0125","doi-asserted-by":"crossref","first-page":"e113161","DOI":"10.1371\/journal.pone.0113161","article-title":"Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration","volume":"9","author":"Silveira","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.01.033_bib0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12640-014-9457-0","article-title":"Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice","volume":"26","author":"Schiavon","year":"2014","journal-title":"Neurotoxic. Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0135","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1111\/ejn.12341","article-title":"Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats","volume":"38","author":"Perez","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0140","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12640-011-9273-8","article-title":"Cannabidiol-treated rats exhibited higher motor score after cryogenic spinal cord injury","volume":"21","author":"Kwiatkoski","year":"2012","journal-title":"Neurotoxic. Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0145","doi-asserted-by":"crossref","first-page":"e28668","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces Abeta-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2016.01.033_bib0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","article-title":"Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors","volume":"59","author":"Mecha","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.01.033_bib0155","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.intimp.2008.11.010","article-title":"Cannabidiol decreases bone resorption by inhibiting RANK\/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats","volume":"9","author":"Napimoga","year":"2009","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0160","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1021\/jm050709m","article-title":"New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity","volume":"49","author":"Ben-Shabat","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2016.01.033_bib0165","doi-asserted-by":"crossref","first-page":"9561","DOI":"10.1073\/pnas.160105897","article-title":"The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis","volume":"97","author":"Malfait","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.01.033_bib0170","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2016.01.033_bib0175","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","article-title":"Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice","volume":"163","author":"Kozela","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0180","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1203\/PDR.0b013e318186e5dd","article-title":"Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets","volume":"64","author":"Alvarez","year":"2008","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0185","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-8-5","article-title":"Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study","volume":"8","author":"Ruiz-Valdepenas","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.phrs.2016.01.033_bib0190","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.phrs.2016.01.033_bib0195","unstructured":"https.\/\/clinicaltrials.gov (accessed 01.16.)."},{"key":"10.1016\/j.phrs.2016.01.033_bib0200","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol: a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.phrs.2016.01.033_bib0205","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ptr.2625","article-title":"Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders","volume":"23","author":"Scuderi","year":"2009","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/3-540-26573-2_11","article-title":"Effects of cannabinoids on neurotransmission","author":"Szabo","year":"2005","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0215","doi-asserted-by":"crossref","first-page":"R549","DOI":"10.1016\/j.cub.2005.07.005","article-title":"Neurotransmission: emerging roles of endocannabinoids","volume":"15","author":"Kreitzer","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0220","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2006.11.063","article-title":"Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson\u2019s disease: importance of antioxidant and cannabinoid receptor-independent properties","volume":"1134","author":"Garcia-Arencibia","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0225","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2005.09.009","article-title":"The cannabinoid receptor antagonist SR-141716A induces penile erection in male rats: involvement of paraventricular glutamic acid and nitric oxide","volume":"50","author":"Melis","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0230","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/glia.20756","article-title":"2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells","volume":"57","author":"Kreutz","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2016.01.033_bib0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2004.01.023","article-title":"6-Azidohex-2-yne-cannabidiol: a potential neutral, competitive cannabinoid CB1 receptor antagonist","volume":"487","author":"Thomas","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0240","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmaco."},{"key":"10.1016\/j.phrs.2016.01.033_bib0245","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0255","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","article-title":"The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors","volume":"37","author":"Castillo","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.01.033_bib0260","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0265","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment","volume":"37","author":"Stern","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0270","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0275","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2013.03.027","article-title":"Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: role of 5HT(1A) and CB2 receptors","volume":"71","author":"Pazos","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0280","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease","volume":"79","author":"Martin-Moreno","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0285","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/cn200114w","article-title":"Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington\u2019s disease: role of CB1 and CB2 receptors","volume":"3","author":"Valdeolivas","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0290","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-8-12","article-title":"Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis","volume":"8","author":"Wolf","year":"2010","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.phrs.2016.01.033_bib0295","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00008877-199708000-00006","article-title":"Drugs acting upon the cyclic adenosine monophosphate\/protein kinase A signalling pathway modulate memory consolidation when given late after training into rat hippocampus but not amygdala","volume":"8","author":"Bevilaqua","year":"1997","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0300","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0305","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0310","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0315","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-010-2157-4","article-title":"Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews","volume":"215","author":"Rock","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0320","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0325","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","article-title":"Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors","volume":"213","author":"Soares V de","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0330","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0335","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0269881110389095","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors","volume":"26","author":"Gomes","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0345","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.euroneuro.2013.10.012","article-title":"Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience","volume":"24","author":"Fogaca","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0350","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0355","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neuropharm.2006.11.005","article-title":"Repeated treatment with cannabidiol but not delta9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance","volume":"52","author":"Hayakawa","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0360","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1476-5381.2009.00589.x","article-title":"Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation","volume":"159","author":"Magen","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0365","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1476-5381.2010.01179.x","article-title":"Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice","volume":"162","author":"Avraham","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0370","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","article-title":"The role of antioxidants in the chemistry of oxidative stress: a review","volume":"97","author":"Pisoschiand","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2016.01.033_bib0375","article-title":"Oxidative stress in neurodegenerative diseases","author":"Niedzielska","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0380","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"Cannabidiol and (\u2212)delta9-tetrahydrocannabinol are neuroprotective antioxidants","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.01.033_bib0385","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)63558-4","article-title":"Neuroprotective effect of (\u2212)delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite","volume":"163","author":"El-Remessy","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0390","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2006.050500","article-title":"Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes","volume":"168","author":"El-Remessy","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0395","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2016.01.033_bib0400","doi-asserted-by":"crossref","first-page":"e331","DOI":"10.1038\/cddis.2012.71","article-title":"Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress","volume":"3","author":"Mecha","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2016.01.033_bib0405","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00018-006-6156-x","article-title":"The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells","volume":"63","author":"Massi","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0410","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-5793(00)01425-3","article-title":"Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3","volume":"472","author":"Sarker","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2016.01.033_bib0415","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0420","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/sj.bjp.0707423","article-title":"Cannabinoids go nuclear: evidence for activation of peroxisome proliferator-activated receptors","volume":"152","author":"O\u2019Sullivan","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0425","doi-asserted-by":"crossref","first-page":"132960","DOI":"10.1155\/2008\/132960","article-title":"Peroxisome proliferator activated receptors and lipoprotein metabolism","volume":"2008","author":"Kersten","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0430","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1017\/neu.2014.24","article-title":"Neuroinflammation as a possible link between cannabinoids and addiction","volume":"26","author":"Rodrigues","year":"2014","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.phrs.2016.01.033_bib0435","doi-asserted-by":"crossref","first-page":"538141","DOI":"10.1155\/2008\/538141","article-title":"Peroxisome proliferator-activated receptors: key regulators of neuroinflammation after traumatic brain injury","volume":"2008","author":"Stahel","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0440","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neulet.2006.01.047","article-title":"Cannabidiol inhibits inducible nitric oxide synthase protein expression and nitric oxide production in beta-amyloid stimulated PC12 neurons through p38 MAP kinase and NF-kappaB involvement","volume":"399","author":"Esposito","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2016.01.033_bib0445","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1164\/rccm.200907-1047OC","article-title":"Nrf2-regulated PPAR{gamma} expression is critical to protection against acute lung injury in mice","volume":"182","author":"Cho","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.phrs.2016.01.033_bib0450","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/j.1476-5381.2011.01461.x","article-title":"Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and delta9-tetrahydrocannabinol in BV-2 microglial cells","volume":"165","author":"Juknat","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0455","first-page":"58","article-title":"Cannabidiol reduces LPS-induced activation and oxidative stress in primary microglial culture via PPARgamma receptor","author":"Sonego","year":"2015","journal-title":"Soc. Neurosci. Annu. Meet."},{"key":"10.1016\/j.phrs.2016.01.033_bib0460","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ptr.5095","article-title":"Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARgamma involvement","volume":"28","author":"Scuderi","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.phrs.2016.01.033_bib0465","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejphar.2012.09.053","article-title":"Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis","volume":"697","author":"Barichello","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0470","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/0269881109106925","article-title":"Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"25","author":"Valvassori","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0475","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.schres.2015.01.015","article-title":"Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol","volume":"164","author":"Gomes","year":"2015","journal-title":"Schizophr. Res."},{"issue":"52","key":"10.1016\/j.phrs.2016.01.033_bib0480","article-title":"Cannabidiol, a non-psychoactive cannabinoid, leads to EGR2-dependent anergy in activated encephalitogenic T cells","volume":"12","author":"Kozela","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.phrs.2016.01.033_bib0485","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","article-title":"Cannabidiol in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression","volume":"151","author":"Esposito","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2016.01.033_bib0490","doi-asserted-by":"crossref","first-page":"S606","DOI":"10.1016\/S0924-977X(14)70972-1","article-title":"Behavioural effects of cannabidiol in chronically stressed mice is mediated by neurogenesis and autophagy through CB1 receptor activation","volume":"24","author":"Foga\u00e7a","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0495","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-015-0703-6","article-title":"Cannabidiol post-treatment alleviates rat epileptic-related behaviors and activates hippocampal cell autophagy pathway along with antioxidant defense in chronic phase of pilocarpine-induced seizure","author":"Hosseinzadeh","year":"2016","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0500","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/ijc.29573","article-title":"Cannabidiol stimulates Aml-1a-dependent glial differentiation and inhibits glioma stem-like cells proliferation by inducing autophagy in a TRPV2-dependent manner","volume":"137","author":"Nabissi","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.phrs.2016.01.033_bib0505","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2016.01.033_bib0510","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neures.2014.04.006","article-title":"Intrahypothalamic injection of cannabidiol increases the extracellular levels of adenosine in nucleus accumbens in rats","volume":"84","author":"Mijangos-Moreno","year":"2014","journal-title":"Neurosci. Res."},{"issue":"12","key":"10.1016\/j.phrs.2016.01.033_bib0515","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor","volume":"49","author":"Liou","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.phrs.2016.01.033_bib0520","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pbb.2015.06.008","article-title":"Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)","volume":"135","author":"Nazario","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.phrs.2016.01.033_bib0525","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1476-5381.2010.01063.x","article-title":"Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action","volume":"162","author":"Maione","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0530","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/00001756-200410250-00016","article-title":"Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism","volume":"15","author":"Hayakawa","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.phrs.2016.01.033_bib0535","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1471-4159.2007.04565.x","article-title":"Delayed treatment with cannabidiol has a cerebroprotective action via a cannabinoid receptor-independent myeloperoxidase-inhibiting mechanism","volume":"102","author":"Hayakawa","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2016.01.033_bib0540","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2004.11.009","article-title":"Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson\u2019s disease","volume":"19","author":"Lastres-Becker","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2016.01.033_bib0545","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10571-013-9984-x","article-title":"Cannabinoid effects on beta amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro","volume":"34","author":"Janefjord","year":"2014","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0550","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuro.2011.12.015","article-title":"Contrasting protective effects of cannabinoids against oxidative stress and amyloid-beta evoked neurotoxicity in vitro","volume":"33","author":"Harvey","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.phrs.2016.01.033_bib0555","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s11481-014-9575-8","article-title":"Neuroprotection in experimental autoimmune encephalomyelitis and progressive multiple sclerosis by cannabis-based cannabinoids","volume":"10","author":"Pryce","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0560","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT(1A) receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2016.01.033_bib0565","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","article-title":"Molecular targets of cannabidiol in neurological disorders","volume":"12","author":"Ibeas Bih","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phrs.2016.01.033_bib0570","first-page":"137","article-title":"Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol","volume":"249","author":"Zuardi","year":"1981","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2016.01.033_bib0575","first-page":"185","article-title":"Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats","volume":"12","author":"Hine","year":"1975","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2016.01.033_bib0580","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00413961","article-title":"Effect of cannabidiol and of other cannabis sativa compounds on hippocampal seizure discharges","volume":"28","author":"Izquierdo","year":"1973","journal-title":"Psychopharmacologia"},{"issue":"3","key":"10.1016\/j.phrs.2016.01.033_bib0585","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington\u2019s disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.phrs.2016.01.033_bib0590","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/cns.12262","article-title":"Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(\u00ae) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis","volume":"20","author":"Moreno-Martet","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2016.01.033_bib0595","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0269215503cr581oa","article-title":"A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms","volume":"17","author":"Wade","year":"2003","journal-title":"Clin. Rehabil."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661816000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T01:16:54Z","timestamp":1567559814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661816000396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":119,"alternative-id":["S1043661816000396"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2016.01.033","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol, neuroprotection and neuropsychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2016.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}